Vandana Surgi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.35 M
as on 17-11-2024
- Paid Up Capital ₹ 1.35 M
as on 17-11-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.23 Cr
as on 17-11-2024
- Satisfied Charges ₹ 1.40 Cr
as on 17-11-2024
- Revenue -41.30%
(FY 2023)
- Profit -67.84%
(FY 2023)
- Ebitda 58.50%
(FY 2023)
- Net Worth 0.40%
(FY 2023)
- Total Assets -26.91%
(FY 2023)
About Vandana Surgi Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.35 M and a paid-up capital of Rs 1.35 M.
The company currently has active open charges totaling ₹2.23 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahaveer Kothari and Vandna Kothari serve as directors at the Company.
- CIN/LLPIN
U24236RJ2004PTC019043
- Company No.
019043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Ajmer, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vandana Surgi Pharma Private Limited offer?
Vandana Surgi Pharma Private Limited offers a wide range of products and services, including Medical & Surgical Clothing, Medical Pads, Bandages & Dressing Disposables, Surgical Cotton, Child and Baby Care Products, Baby Care Products, Absorbent Cotton, Baby Wipe, Sanitary Pad, Sanitary Napkins.
Who are the key members and board of directors at Vandana Surgi Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahaveer Kothari  | Director | 27-Feb-2004 | Current |
| Vandna Kothari | Director | 14-Aug-2006 | Current |
Financial Performance of Vandana Surgi Pharma.
Vandana Surgi Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.3% decrease. The company also saw a substantial fall in profitability, with a 67.84% decrease in profit. The company's net worth moved up by a moderate rise of 0.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vandana Surgi Pharma?
In 2023, Vandana Surgi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 10 Jan 2024 | ₹8.60 M | Open |
Others Creation Date: 08 Feb 2022 | ₹6.00 M | Open |
Others Creation Date: 20 Aug 2020 | ₹1.07 M | Open |
How Many Employees Work at Vandana Surgi Pharma?
Unlock and access historical data on people associated with Vandana Surgi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vandana Surgi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vandana Surgi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
